D. Cosgrove

发表

Knockin of mutant PIK3CA activates multiple oncogenic pathways

B. Park, K. Bachman, H. Konishi, 2009, Proceedings of the National Academy of Sciences.

Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells

Hiroyuki Konishi, David Cosgrove, Yuko Konishi, 2011, Proceedings of the National Academy of Sciences.

Hilar cholangiocarcinoma: diagnosis, treatment options, and management.

T. Pawlik, I. Kamel, J. Herman, 2014, Hepatobiliary surgery and nutrition.

Liver Resection for Advanced Intrahepatic Cholangiocarcinoma: A Cost-Utility Analysis

A. Ejaz, G. Spolverato, T. Pawlik, 2015, World Journal of Surgery.

Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis

A. Ejaz, G. Spolverato, T. Pawlik, 2015, Journal of Gastrointestinal Surgery.

Cadmium Exposure and Liver Disease among US Adults

T. Pawlik, J. Herman, O. Hyder, 2013, Journal of Gastrointestinal Surgery.

Open-Label Single-Arm Phase II Trial of Sorafenib Therapy with Drug-eluting Bead Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Clinical Results.

T. Pawlik, I. Kamel, J. Geschwind, 2015, Radiology.

The PIK3CA gene as a mutated target for cancer therapy.

B. Park, J. Gustin, D. Cosgrove, 2008, Current cancer drug targets.

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

A. Weeraratna, P. Argani, A. D. De Marzo, 2012, Breast Cancer Research.

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.

T. Pawlik, I. Kamel, N. Bhagat, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Net health benefit of hepatic resection versus intraarterial therapies for neuroendocrine liver metastases: A Markov decision model.

A. Ejaz, G. Spolverato, Yuhree Kim, 2015, Surgery.

PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human breast epithelial cells

B. Park, H. Konishi, M. Mohseni, 2011, Cancer biology & therapy.

Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations

B. Vogelstein, K. Polyak, D. Gorkin, 2010, Oncogene.

Infiltrating Hepatocellular Carcinoma: Seeing the Tree through the Forest

T. Pawlik, I. Kamel, A. Demirjian, 2011, Journal of Gastrointestinal Surgery.

Pattern of distant metastases in colorectal cancer: a SEER based study

Dajun Yang, R. Xu, M. Qiu, 2015, Oncotarget.

Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.

M. Choti, A. Ejaz, G. Spolverato, 2015, JAMA surgery.

Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.

M. Choti, T. Pawlik, M. Torbenson, 2013, Gastrointestinal cancer research : GCR.

Intrahepatic cholangiocarcinoma: management options and emerging therapies.

David Cosgrove, Timothy M Pawlik, Robert Anders, 2013, Journal of the American College of Surgeons.

Diabetes and pancreatic cancer.

H. Yeh, R. Kalyani, Erica Hall, 2013, Current problems in cancer.

Impact of Sarcopenia on Outcomes Following Intra-arterial Therapy of Hepatic Malignancies

Rebecca M. Dodson, T. Pawlik, I. Kamel, 2013, Journal of Gastrointestinal Surgery.

Chromophobe hepatocellular carcinoma with abrupt anaplasia: a proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features

B. Naini, L. Wood, I. Kamel, 2013, Modern Pathology.

Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy.

Celia P. Corona-Villalobos, T. Pawlik, I. Kamel, 2013, Radiology.

Patterns of Consultation and Treatment of Patients with Hepatocellular Carcinoma Presenting to a Large Academic Medical Center in the US

T. Pawlik, I. Kamel, O. Hyder, 2013, Journal of Gastrointestinal Surgery.

Treating Patients with Colon Cancer Liver Metastasis: A Nationwide Analysis of Therapeutic Decision Making

M. Choti, T. Pawlik, L. Diaz, 2012, Annals of Surgical Oncology.

Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.

T. Pawlik, I. Kamel, N. Bhagat, 2013, Journal of the American College of Surgeons.

The Relative Net Health Benefit of Liver Resection, Ablation, and Transplantation for Early Hepatocellular Carcinoma

A. Ejaz, G. Spolverato, Yuhree Kim, 2015, World Journal of Surgery.

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

A. Weeraratna, P. Argani, A. D. De Marzo, 2012, Breast Cancer Research.

Referral patterns and treatment choices for patients with hepatocellular carcinoma: a United States population-based study.

Rebecca M. Dodson, T. Pawlik, I. Kamel, 2013, Journal of the American College of Surgeons.

Neuroendocrine tumor liver metastases treated with yttrium-90 radioembolization.

T. Pawlik, I. Kamel, K. Hong, 2016, Contemporary clinical trials.

Multidisciplinary Management of Recurrent Hepatocellular Carcinoma Following Liver Transplantation

T. Pawlik, I. Kamel, P. Kneuertz, 2012, Journal of Gastrointestinal Surgery.